On the other hand, one small study has revealed that serum hepcidin is increased in patients with bone metastasis, and that the increase in serum hepcidin is partly related to cytokine production, such as IL6, which is a known upregulator of hepcidin (97). This evidence concerns the gene HAMP and bone metastasis.